US Army’s Biomedical Research Lab, Immuron Partner for Shigella Vaccine Development
Australia-based bioptechnology company Immuron has signed a partnership agreement with a U.S. Army-run biomedical research institute to research and develop a vaccine against shigella gram-negative bacteria that cause intestinal diseases. Immuron and the the Walter Reed Army Institute of Research aim to produce a shigella vaccine for potential government, military and commercial applications, the company said Thursday. “This partnership will potentially provide […] More